Cannabinoids Clinical Trials Data Packaging 
Cannabis Law Report
OCTOBER 6, 2021
Flora Pharma will seek to identify scientific gaps in the cannabis industry and ultimately work to translate that to pharmaceutical cannabis products backed by data. The immediate next steps are to submit data for ethics committee review and approval whereupon acceptance, further details will be provided. “A
Cannabis Law Report
AUGUST 23, 2021
Oxford Cannabinoid Technologies Holdings plc. At the end of the programme, Evotec will provide the Company with a submission-ready regulatory document which will be used for submissions to regulatory agencies, as well as drug-batch approved and ready for First Time in Human clinical trials. & Notice of 2021 Final Results.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
SEPTEMBER 14, 2021
A lack of consumer trust, transparency and scientific rigor has hampered the CBD and cannabinoid industry from reaching its growth potential for far too long”. Step four: Brands select packaging, labels and other physical concepts for the selected product in a fully customizable experience.
Weedistry
MARCH 11, 2019
The packaging, with a baronial crest and gold accents, would look at home in a fashionable department store. A lot of my friends have been getting their products from more ‘luxury’ cannabis suppliers who are focusing on packaging and branding,” he said. It’s hard to tell because we don’t have the data and studies. Idriss said.
Cannabis Law Report
JULY 23, 2019
Businesses preparing to market a new product nationally must follow the rules of trademark law as well as marketing and advertising claims under state and US laws when creating a trademark, advertising copy and copyright-registered packaging for the product. This is particularly the case for cannabis and cannabidiol (CBD) products.
Puff Puff Post
NOVEMBER 5, 2019
. (“InMed” or the “Company”) (TSX: IN; OTCQX: IMLFF), today announced the filing of a Clinical Trial Application (“CTA”) in the Netherlands to initiate a Phase 1 human clinical trial for INM-755 in healthy volunteers. For more information, visit www.inmedpharma.com. About INM-755.
Cannabis Law Report
JANUARY 9, 2019
Armed with their mission, in June 2018, Phoenix merged many of its partnership organisations together under the name Phoenix Life Sciences International Limited, placing expert botanists, biologists, industrial and organic chemists, medical doctors, researchers, packagers and distributors together under one roof.
Expert insights. Personalized for you.
52 
Let's personalize your content